PUBLICATION

Functional evolution of the vitamin D and pregnane X receptors

Authors
Reschly, E.J., Bainy, A.C., Mattos, J.J., Hagey, L.R., Bahary, N., Mada, S.R., Ou, J., Venkataramanan, R., and Krasowski, M.D.
ID
ZDB-PUB-071118-47
Date
2007
Source
BMC Evolutionary Biology   7: 222 (Journal)
Registered Authors
Bahary, Nathan
Keywords
none
MeSH Terms
  • Animals
  • Biological Evolution*
  • Cell Line
  • Ciona intestinalis
  • Hepatocytes/metabolism
  • Humans
  • Hydroxylation
  • Ligands
  • Mice
  • Petromyzon
  • Receptors, Calcitriol/drug effects
  • Receptors, Calcitriol/genetics
  • Receptors, Calcitriol/metabolism*
  • Receptors, Steroid/drug effects
  • Receptors, Steroid/genetics
  • Receptors, Steroid/metabolism*
  • Species Specificity
  • Testosterone/metabolism
  • Transcriptional Activation
  • Transfection
  • Xenopus
  • Zebrafish
PubMed
17997857 Full text @ BMC Evol. Biol.
CTD
17997857
Abstract
BACKGROUND: The vitamin D receptor (VDR) and pregnane X receptor (PXR) are nuclear hormone receptors of the NR1I subfamily that show contrasting patterns of cross-species variation. VDR and PXR are thought to have arisen from duplication of an ancestral gene, evident now as a single gene in the genome of the chordate invertebrate Ciona intestinalis (sea squirt). VDR genes have been detected in a wide range of vertebrates including jawless fish. To date, PXR genes have not been found in cartilaginous fish. In this study, the ligand selectivities of VDRs were compared in detail across a range of vertebrate species and compared with those of the Ciona VDR/PXR. In addition, several assays were used to search for evidence of PXR-mediated hepatic effects in three model non-mammalian species: sea lamprey (Petromyzon marinus), zebrafish (Danio rerio), and African clawed frog (Xenopus laevis). RESULTS: Human, mouse, frog, zebrafish, and lamprey VDRs were found to have similar ligand selectivities for vitamin D derivatives. In contrast, using cultured primary hepatocytes, only zebrafish showed evidence of PXR-mediated induction of enzyme expression, with increases in testosterone 6beta-hydroxylation activity (a measure of cytochrome P450 3A activity in other species) and flurbiprofen 4-hydroxylation activity (measure of cytochrome P450 2C activity) following exposure to known PXR activators. A separate assay in vivo using zebrafish demonstrated increased hepatic transcription of another PXR target, multidrug resistance gene (ABCB5), following injection of the major zebrafish bile salt, 5alpha-cyprinol 27-sulfate. The PXR target function, testosterone hydroxylation, was detected in frog and sea lamprey primary hepatocytes, but was not inducible in these two species by a wide range of PXR activators in other animals. Analysis of the sea lamprey draft genome also did not show evidence of a PXR gene. CONCLUSIONS: Our results show tight conservation of ligand selectivity of VDRs across vertebrate species from Agnatha to mammals. Using a functional approach, we demonstrate classic PXR-mediated effects in zebrafish, but not in sea lamprey or African clawed frog liver cells. Using a genomic approach, we failed to find evidence of a PXR gene in lamprey, suggesting that VDR may be the original NR1I gene.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping